The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight loss, but there are doubts over their long-term safety. New drugs such as lorcaserin and phentermine ...

After a nurse practitioner was acquitted of illegally prescribing controlled substances, she sues the United States Government and the Drug Enforcement Administration (DEA) Diversion Investigator. The ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...